Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction()

BACKGROUND: Approximately 15.5 million deaths from cardiovascular diseases occur every year. About half are due to acute myocardial infarction (AMI), and 80% occur in low- and middle-income countries. Therefore, low-cost therapies would be invaluable. Although glucose-insulin-potassium (GIK) infusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yusuf, Salim, Mehta, Shamir R., Díaz, Rafael, Paolasso, Ernesto, Pais, Prem, Xavier, Denis, Xie, Changchun, Ahmed, Rashid J., Khazmi, Khawar, Zhu, Jun, Liu, Lisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118878/
https://www.ncbi.nlm.nih.gov/pubmed/15632895
http://dx.doi.org/10.1016/j.ahj.2004.08.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118878/
https://www.ncbi.nlm.nih.gov/pubmed/15632895
http://dx.doi.org/10.1016/j.ahj.2004.08.033

Ejemplares similares